... improvement in treatment satisfaction without a substantial change in glycosylated hemoglobin A 1c (HbA 1c ). Elevated levels of HbA 1c not only at the start of CSII, but also during the follow-up, may be an important indicator of pump discontinuation. Sensor-augmented pump therapy (SAP) has a more...

... enterocytes rather than hepatocytes may serve as energy flow sensors in the control of eating. These recent developments are discussed here and an outline is given of the challenges of this promising new concept. By providing fuels and essential nutrients, eating is part of the vital regulatory...

... Abstract In the emerging field of synthetic biology, a central goal is to reliably engineer bacteria to respond to environmental signals according to a pre-determined genetic program. The sensor systems and genetic circuitry inside bacteria are the ‘eyes’ and ‘brain’ of a new class...

... seeking alternative routes of glucose measurement. New models of continuous glucose monitors are being pursued including implantable, intraperitoneal, and fluorescence-based glucose sensors, as well as noninvasive models that are used on the surface of the skin. Regardless of system type, the ultimate...

... Abstract In type 1 diabetes, severe hypoglycemia is a barrier to optimal metabolic control. The combination of a continuous glucose sensor and an insulin pump with a mechanism of automatic shut-off in the presence of low glucose values [low glucose suspend (LGS)] can be used to reduce the risk...

..., and thorough patient education. Although obviously more expensive than MDI, CSII may be cost-effective when elevated HbA 1c levels or continued disabling hypoglycemia persist despite optimized MDI therapy. More recently, sensor-augmented pumps (SAPs) have become available. These combine the technology...

... cardiocirculatory instability but also to control the dialysis efficiency (biofeedbackcontrol systems). The basic components of a biofeedback system are: the plant, the sensors,the actuators and the controller. The plant is the biological process that we need to control,while the sensors are the devices used...

... it easier to adapt therapy immediately. Currently approved RTCGM devices consist of three main components: a glucose sensor, a transmitter, and a receiver monitor. The system is defined as minimally invasive because it requires insertion into the subcutaneous cellular tissue of a fine needle to measure...

... disorder patients . IEEE J Biomed Health Inform . 2015 ; 19 ( 1 ): 140 – 8 . 11. Shoaib M , Bosch S , Incel OD , Scholten H , Havinga PJ . Fusion of smartphone motion sensors for physical activity recognition . Sensors (Basel) . 2014 ; 14 ( 6 ): 10146 – 76 . 12...